about
Cellular replacement therapy for Parkinson's disease--where we are today?Therapeutic concentrations of glucagon-like peptide-1 in cerebrospinal fluid following cell-based delivery into the cerebral ventricles of catsAdenosine augmentation therapies (AATs) for epilepsy: prospect of cell and gene therapies.Molecular mechanisms and potential therapeutical targets in Huntington's disease.Clinical translation of stem cell therapy in traumatic brain injury: the potential of encapsulated mesenchymal cell biodelivery of glucagon-like peptide-1.De Novo Arteriovenous Malformation Growth Secondary to Implantation of Genetically Modified Allogeneic Mesenchymal Stem Cells in the Brain.
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Encapsulated neural transplants.
@ast
Encapsulated neural transplants.
@en
Encapsulated neural transplants.
@nl
type
label
Encapsulated neural transplants.
@ast
Encapsulated neural transplants.
@en
Encapsulated neural transplants.
@nl
prefLabel
Encapsulated neural transplants.
@ast
Encapsulated neural transplants.
@en
Encapsulated neural transplants.
@nl
P1476
Encapsulated neural transplants.
@en
P2093
P304
P356
10.1016/S0079-6123(00)27010-6
P577
2000-01-01T00:00:00Z